PuraPharm Corp. Ltd.'s market cap is currently HK$217.22M. The company's EPS TTM is HK$-0.22; its P/E ratio is ―; PuraPharm Corp. Ltd. is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	HK$ 406.86M	HK$ 448.07M	HK$ 659.59M	HK$ 601.82M	HK$ 695.88M
Gross Profit	HK$ 216.63M	HK$ 260.59M	HK$ 421.85M	HK$ 368.69M	HK$ 397.59M
Operating Income	HK$ -66.05M	HK$ -64.50M	HK$ 17.62M	HK$ -4.88M	HK$ -61.25M
EBITDA	HK$ -26.17M	HK$ -46.34M	HK$ -40.03M	HK$ 114.67M	HK$ -122.19M
Net Income	HK$ -106.08M	HK$ -120.21M	HK$ -121.88M	HK$ 31.71M	HK$ -227.26M
Balance Sheet
Cash & Short-Term Investments	HK$ 47.22M	HK$ 107.01M	HK$ 85.05M	HK$ 126.46M	HK$ 93.12M
Total Assets	HK$ 843.96M	HK$ 1.02B	HK$ 1.21B	HK$ 1.37B	HK$ 1.22B
Total Debt	HK$ 424.77M	HK$ 503.16M	HK$ 531.96M	HK$ 524.11M	HK$ 541.53M
Net Debt	HK$ 404.64M	HK$ 396.14M	HK$ 446.90M	HK$ 397.65M	HK$ 448.41M
Total Liabilities	HK$ 690.73M	HK$ 757.18M	HK$ 803.13M	HK$ 859.07M	HK$ 858.08M
Stockholders' Equity	HK$ 153.24M	HK$ 258.29M	HK$ 401.56M	HK$ 511.66M	HK$ 362.12M
Cash Flow
Free Cash Flow	HK$ 57.95M	HK$ 42.29M	HK$ -45.89M	HK$ 3.84M	HK$ 4.98M
Operating Cash Flow	HK$ 79.61M	HK$ 65.85M	HK$ -39.33M	HK$ 86.68M	HK$ 101.94M
Investing Cash Flow	HK$ -18.20M	HK$ -25.45M	HK$ -3.67M	HK$ -82.17M	HK$ -75.35M
Financing Cash Flow	HK$ -122.39M	HK$ -12.94M	HK$ 8.77M	HK$ 29.56M	HK$ -49.98M

Currency in HKD

PuraPharm Corp. Ltd. Earnings and Revenue History

Income Statement >

PuraPharm Corp. Ltd. Debt to Assets

Balance Sheet >

PuraPharm Corp. Ltd. Cash Flow

Cash Flow >

PuraPharm Corp. Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing